Vajdic Branislav 4
4 · HeartBeam, Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
HeartBeam, Inc.BEAT
Vajdic Branislav
DirectorPresident
Transactions
- Award
Stock option (right to buy)
2023-05-14+398,000→ 398,000 totalExp: 2033-05-13→ Common Stock (398,000 underlying)
Footnotes (3)
- [F1]The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as .
- [F2]The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023.
- [F3]The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.